4
Changes in Ownership
Inogen Inc Filed Acc 0000950170-24-053100
EVP, R&D & Chief Med. Officer gave up 16,695 shares (to pay taxes)
- EVP, R&D & Chief Med. Officer acquired 32,638 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Glezer Stanislav EVP, R&D & Chief Med. Officer | 2024-05-01 | Option exercise | +32,638 | 48,744 | D | ||
| Glezer Stanislav EVP, R&D & Chief Med. Officer | 2024-05-01 | Shares withheld for taxes | −16,695 | $7.05 | $117,700 | 32,049 | D |
| Derivatives | |||||||
| Glezer Stanislav EVP, R&D & Chief Med. Officer | 2024-05-01 | Option exercise · Restricted Stock Unit | −32,638 | 0 | D | ||
Loading xslF345X05/ownership.xml…